Teva Pharmaceuticals Usa, Inc: Trazodone Hydrochloride Tablets, Usp, 50 Mg

Teva Pharmaceuticals is recalling trazodone hydrochloride 50 mg tablets nationwide because some bottles contain foreign tablets or capsules mixed in with the medication. The affected product is a 100-tablet bottle with NDC number 50111-560-01, distributed across all U.S. states and Washington, D.C.

Recalling firm

Teva Pharmaceuticals USA, Inc

Product

traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01

Reason

Presence of Foreign Tablets/Capsules

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-08-24

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

U.S. Nationwide

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/fbc39e86-13ae-452c-9066-9aaad26f1295